Mutation of arginine to glutamine at position 140(R140Q) of isocitrate dehydrogenase 2 (IDH2) is closely related to the tumorigenesis of AML, and approximately 10% of patients with AML carry the IDH2/R140Q mutation [1, 2]. The gene discussed is IDH2; the disease is acute myeloid leukemia.